14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:MNTA
Delisted

Momenta Pharmaceuticals Stock Predictions

$52.48
+0 (+0%)
At Close: May 27, 2022
Currently predicting for Mon, 6 May 2024

MNTA Predictions History

4 years ago
JS predicted that MNTA for 2019-10-22 is going $14.28 (-2.06%)

4 years ago
2poJeff predicted that MNTA for 2019-10-22 is going $14.11 (-1.81%)

4 years ago
Omar.Zaied.111919 predicted that MNTA for 2019-10-22 is going $14.40 (0.21%)

Rank:

4 years ago
GoldenNugget predicted that MNTA for 2019-05-07 is going $14.51 (-3.25%)

5 years ago
NameNotImportant predicted that MNTA for 2019-04-24 is going $14.32 (-0.49%)

5 years ago
NameNotImportant predicted that MNTA for 2019-04-23 is going $13.95 (-5.10%)

7 years ago
JS predicted that MNTA for 2016-08-26 is going $12.42 (-2.28%)

7 years ago
PumpTheseNumbers predicted that MNTA for 2016-05-24 is going $10.17 (-3.60%)

7 years ago
PumpTheseNumbers predicted that MNTA for 2016-05-20 is going $10.24 (1.69%)

7 years ago
JS predicted that MNTA for 2016-05-19 is going $10.24 (-0.10%)

Click to get the best stock tips daily for free!

About Momenta Pharmaceuticals

Momenta Pharmaceuticals Momenta Pharmaceuticals, Inc., a biotechnology company, focuses on developing generic versions of complex drugs, biosimilars, and novel therapeutics for oncology and autoimmune diseases. The company’s complex generics programs include Enoxaparin sodium injection, a generic version of Lovenox that is used to prevent and treat deep vein thrombosis, and to support the treatment of acute coronary syndromes; GLATOPA, a generic version of once-daily C... MNTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT